Abstract

GATA-1, known primarily for its role in hematopoiesis, has emerged as a critical modulator of immune responses in Human Immunodeficiency Virus (HIV)-infected individuals. This review explores the multifaceted role of GATA-1 in modulating immune responses during HIV infection, highlighting its impact on T-cell function, cytokine signaling, and inflammatory pathways. Dysregulation of GATA-1 activity contributes to immune dysfunction, chronic inflammation, and disease progression in HIV-infected individuals. Therapeutic implications of targeting GATA-1 as a novel approach to mitigate immune dysregulation in HIV infection are also discussed. Understanding the interplay between GATA-1 and immune responses in HIV infection offers insights into disease pathogenesis and identifies potential therapeutic targets for improving clinical outcomes.